000075988 001__ 75988
000075988 005__ 20200117221611.0
000075988 0247_ $$2doi$$a10.1097/MD.0000000000012486
000075988 0248_ $$2sideral$$a109067
000075988 037__ $$aART-2018-109067
000075988 041__ $$aeng
000075988 100__ $$aRamos, A.
000075988 245__ $$aValidation of a self-reported work disability questionnaire for ulcerative colitis
000075988 260__ $$c2018
000075988 5060_ $$aAccess copy available to the general public$$fUnrestricted
000075988 5203_ $$aUlcerative colitis (UC) may severely limit patients'' capacity to work. Recently, we validated a work disability questionnaire (WDQ) for Crohn disease. As UC shares clinical characteristics with Crohn disease, we hypothesized that the questionnaire might also be useful for UC. The study was aimed to validate the WDQ for use in UC. Consecutive patients with UC (n = 142, 67 women; age 48 +/- 1) completed the UC-WDQ and the inflammatory bowel disease questionnaire-9 (IBDQ-9), and EuroQoL-5D quality-of-life questionnaires. Validation of the UC-WDQ included an assessment of its construct validity, including: discriminant validity, convergent validity, and reproducibility (test-retest). We also calculated the intraclass correlation and the Cronbach alpha. 1. Discriminant validity: Mean UC-WDQ scores were 12.8 +/- 4.4 (remission phase) and 17.2 +/- 6.1 (with clinical activity) (P < .05). 2. Convergent validity: The correlations of UC-WDQ were r = 0.74 (P < .001) with IBDQ, r = 0.44 (P < .01) with disease activity, r = 0.56 (P < .01) with EuroQoL-5D, and r = 0.60 (P < .01) with the EuroQoL-5D visual scale. 3. Reproducibility: Test-retest reproducibility: UC-WDQ scores obtained after a 2-week interval were similar (15.8 vs 15.1), (r = 0.91, P < .01). Intraclass correlation was 0.93 (95% confidence interval 0.92-0.95). Cronbach alpha was 0.94. The UC-WDQ is a valid and reliable tool for measuring work disability in patients with UC.
000075988 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-sa$$uhttp://creativecommons.org/licenses/by-nc-sa/3.0/es/
000075988 590__ $$a1.87$$b2018
000075988 591__ $$aMEDICINE, GENERAL & INTERNAL$$b69 / 159 = 0.434$$c2018$$dQ2$$eT2
000075988 592__ $$a0.19$$b2018
000075988 593__ $$aMedicine (miscellaneous)$$c2018$$dQ3
000075988 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000075988 700__ $$aVergara, M.
000075988 700__ $$aMelcarne, L.
000075988 700__ $$aSicilia, B.
000075988 700__ $$0(orcid)0000-0003-0076-3529$$aGomollon, F.$$uUniversidad de Zaragoza
000075988 700__ $$aCalvet, X.
000075988 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000075988 773__ $$g97, 39 (2018), e12486 [5 pp]$$pMedicine (Baltim.)$$tMedicine$$x0025-7974
000075988 8564_ $$s159413$$uhttps://zaguan.unizar.es/record/75988/files/texto_completo.pdf$$yVersión publicada
000075988 8564_ $$s87850$$uhttps://zaguan.unizar.es/record/75988/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000075988 909CO $$ooai:zaguan.unizar.es:75988$$particulos$$pdriver
000075988 951__ $$a2020-01-17-21:48:46
000075988 980__ $$aARTICLE